asthma

Graphic image of an arrow nailing the bullseye of a target
Biotech

Areteia posts ph. 3 asthma win for oral rival to biologic drugs

Three years on from a splashy unveiling, Areteia has reported data that could boost its bid to disrupt a multibillion-dollar asthma market.
Nick Paul Taylor Sep 16, 2025 9:20am
Apple trees in an orchard

Enveda harvests another $150M to advance nature-inspired drugs

Sep 4, 2025 9:14am
data error magnifying glass inspection mistake

Jasper warns of restructuring after dud drug derails trials

Jul 7, 2025 9:23am
Compressor inhaler with childs mask and pocket device for asthmatics on background of table

Vaccine protects mice from allergic reactions for a year

Apr 17, 2025 1:04pm
Sanofi

Sanofi's hopes for $1.1B Kymab drug dented after ph. 2 asthma fail

Apr 15, 2025 7:34am
windmill turbines in the Netherlands

Windward generates $200M with Novo Holdings, OrbiMed in tow

Jan 10, 2025 10:02am